Topic Review
WD Repeat Domain 5 Inhibitors for Cancer Therapy
WDR5 is a conserved nuclear protein that scaffolds the assembly of epigenetic regulatory complexes and moonlights in functions ranging from recruiting MYC oncoproteins to chromatin to facilitating the integrity of mitosis. It is also a high-value target for anti-cancer therapies, with small molecule WDR5 inhibitors and degraders undergoing extensive preclinical assessment. WDR5 inhibitors were originally conceived as epigenetic modulators, proposed to inhibit cancer cells by reversing oncogenic patterns of histone H3 lysine 4 methylation—a notion that persists to this day.
  • 103
  • 15 Jan 2024
Topic Review
Vulvar and Vaginal Melanomas
Melanomas of the skin are poorly circumscribed lesions, very frequently asymptomatic but unfortunately with a continuous growing incidence. In this landscape, one can distinguish melanomas originating in the mucous membranes and located in areas not exposed to the sun, namely the vulvo-vaginal melanomas. By contrast with cutaneous melanomas, the incidence of these types of melanomas is constant, being diagnosed in females in their late sixties. While hairy skin and glabrous skin melanomas of the vulva account for 5% of all cancers located in the vulva, melanomas of the vagina and urethra are particularly rare conditions. The location in areas less accessible to periodic inspection determines their diagnosis in advanced stages, often metastatic. 
  • 1.4K
  • 22 Sep 2021
Topic Review
Von Hippel–Lindau Disease
Over the last several decades, an improved understanding of von Hippel–Lindau disease and its underlying biology has informed the successful development of numerous anti-cancer agents, particularly for the treatment of advanced renal cell carcinoma.
  • 316
  • 18 Nov 2022
Topic Review
Vitamins and Cancer
There is a large body of evidence suggesting a strong correlation between vitamin intake as well as vitamin blood concentrations with the occurrence of certain types of cancer. The direction of association between the concentration of a given vitamin and cancer risk is tumor specific.
  • 453
  • 19 Nov 2021
Topic Review
Vitamin D3 Hydroxyderivatives in Human
itamin D3 (D3) is produced in the skin in two steps. Initially there is a photochemical reaction caused by the action of UVB radiation (290–315 nm) on 7-dehydrocholesterol (7DHC) in which the B ring is broken producing pre-vitamin D3. In the second reaction, vitamin D3 is formed from pre-vitamin D3 by its thermal isomerization at 37 °C over several hours. Both the UVB intensity and the level of skin pigmentation affect the rate of vitamin D3 production. Vitamin D3 is a fat-soluble prohormonal secosteroid that has endocrine, paracrine and autocrine functions. Melanin absorbs UVB limiting the production of D3, and the same effect is achieved with clothing and sunscreen. Skin, more specifically the epidermis, has the full capacity to produce and activate vitamin D3.
  • 464
  • 07 Jul 2021
Topic Review
Vitamin D, Sun Exposure and Skin Cancer
The current vitamin D deficiency epidemic is accompanied by an increase in endemic skin cancer. Ultraviolet (UV) exposure (neither artificial nor natural) is not the ideal source to synthesize vitamin D. There is conflicting epidemiological evidence regarding vitamin D, non-melanoma skin cancer (NMSC), and cutaneous melanoma (CMM), confounded by the effect of sun exposure and other factors. 
  • 346
  • 29 Mar 2022
Topic Review
Vitamin D in NF1
Vitamin D is a fat-soluble steroid hormone playing a pivotal role in calcium and phosphate homeostasis as well as in bone health. Several investigations indicated that vitamin D action extends far beyond bone health and calcium metabolism, showing broad effects on a variety of critical illnesses, including cancer, infections, cardiovascular and autoimmune diseases. Epidemiological studies indicated that low circulating vitamin D levels inversely correlate with cutaneous manifestations and bone abnormalities, clinical hallmarks of neurofibromatosis type 1 (NF1). NF1 is an autosomal dominant tumour predisposition syndrome causing significant pain and morbidity, for which limited treatment options are available.
  • 862
  • 29 Jan 2021
Topic Review
Vitamin D arrests cell cycling
Vitamin D is a steroid hormone crucial for bone mineral metabolism. In addition, vitamin D has pleiotropic actions in the body, including anti-cancer actions. These anti-cancer properties observed within in vitro studies frequently report the reduction of cell proliferation by direct alteration of cell cycle regulators which induce cell cycle arrest. The most recurrent reported mode of cell cycle arrest by vitamin D is at the G1/G0 phase of the cell cycle. This arrest is mediated by p21 and p27 upregulation, which results in suppression of cyclin D and E activity which leads to G1/G0 arrest. In addition, vitamin D treatments within in vitro cell lines have observed a reduced C-MYC expression and increased retinoblastoma protein levels that also result in G1/G0 arrest.
  • 789
  • 16 Dec 2020
Topic Review
Vitamin C in Treatment of Patients with Cancer
Vitamin C is an essential micronutrient, that plays an important role in numerous physiological processes in the human body. Vitamin C stimulates the production and activation of immune cells, so perhaps supplementation could be used to improve the immunity in cancer patients .
  • 342
  • 04 Aug 2022
Topic Review
Vitamin A and Bladder Cancer
Bladder cancer (BC) is the tenth most common cancer worldwide with a high recurrence rate, morbidity and mortality. Therefore, chemoprevention and improved treatment of BC are of paramount importance. Epidemiological studies suggest that adequate vitamin A intake may be associated with reduced BC risk. In addition, retinoids, natural and synthetic derivatives of vitamin A, are intensively studied in cancer research due to their antioxidant properties and their ability to regulate cell growth, differentiation, and apoptosis. Findings from in vivo and in vitro models of BC show great potential for the use of retinoids in the chemoprevention and treatment of BC. However, translation to the clinical practice is limited.
  • 420
  • 25 Apr 2021
  • Page
  • of
  • 256